The example Rory used to explain the potential for NotifiMed was interesting. Previously he’s described it at a means for facilitating routine follow up visits to improve processes and outcomes. Private sector utility. This is the first time that he’s really gone all in with this partnership for data collection for clinical trials. Which honestly can be extrapolated to just about any industry if/when this proves to be a more reliable tool to do so. Another topic for another day. My larger point is, any affiliation with clinical trials would require FDA/gov’t coordination and approval. If a federal agency views this technology as a vast upgrade in this area, the sky is the limit for its adoption once Uncle Sam gets a hold of it. One can dream, right??